2011 - 10th Meeting - IHCTAS


Plenary Session II. Part 2: Infectious Disease Session

4.2 - Infection Prophylaxis for Induction and Rescue Therapies

Presenter: Camille N., Kotton, Boston, MA, USA
Authors: Camille N. Kotton


Infection Prophylaxis for Induction and Rescue Therapies

Camille N. Kotton, Massachusetts General Hospital, Boston, MA, USA.

Learning Objectives:

  1. Discuss the common methods used to prevent infection in organ transplant recipients, including antiviral, antibacterial, antiparasitic, and antifungal therapies
  2. Describe both routine and specialized pre-transplant evaluation techniques to enhance the post-transplant safety
  3. Discuss vaccine techniques that can be used to provide an additional level of protection against infection

Abstract: Solid organ transplant recipients are more vulnerable to infection. Numerous techniques can be employed to reduce their risk of infection, both pre- and post-transplant, ranging from medications to better screening to optimizing vaccinations. Composite tissue transplant recipients have had high rates of CMV infection and complications; with optimal management, this risk can be significantly mitigated. During this talk, Dr. Kotton will discuss methods to prevent (and optimally manage) infection, thus decreasing morbidity, mortality, and enhancing overall transplant outcomes.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi